| Immune activation by combination human lymphokine-activated killer and dendritic cell therapy. | |
| | |
MedLine Citation:
|
PMID: 21847125 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background:Optimal cellular immunotherapy for cancer should ideally harness both the innate and adaptive arms of the immune response. Lymphokine-activated killer cells (LAKs) can trigger early innate killing of tumour targets, whereas long-term adaptive-specific tumour control requires priming of CD8+ cytotoxic lymphocytes (CTLs) following acquisition of tumour-associated antigens (TAAs) by antigen-presenting cells such as dendritic cells (DCs). As DCs stimulate both innate and adaptive effectors, combination cell therapy using LAKs and DCs has the potential to maximise anti-tumour immune priming.Methods:Reciprocal activation between human clinical grade LAKs and DCs on co-culture, and its immune consequences, was monitored by cell phenotype, cytokine release and priming of both innate and adaptive cytotoxicity against melanoma targets.Results:Co-culture of DCs and LAKs led to phenotypic activation of natural killer (NK) cells within the LAK population, which was associated with increased production of inflammatory cytokines and enhanced innate cytotoxicity against tumour cell targets. The LAKs reciprocally matured DCs, and the combination of LAKs and DCs, on addition of melanoma cells, supported priming of specific anti-tumour CTLs better than DCs alone.Conclusion:Clinical-grade LAKs/DCs represents a practical, effective combination cell immunotherapy for stimulation of both innate and adaptive anti-tumour immunity in cancer patients.British Journal of Cancer advance online publication, 16 August 2011; doi:10.1038/bjc.2011.290 www.bjcancer.com. |
| | |
Authors:
|
E J West; K J Scott; V A Jennings; A A Melcher |
Related Documents
:
|
10217305 - Murine microglial cells produce and respond to interleukin-18. 17289835 - (s)-1-((s)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyr... 20428785 - Development of selective immune tolerance towards the allogeneic fetus during pregnancy... 10505105 - Potent antitumor effects mediated by local expression of the mature form of the interfe... 9605105 - Apoptosis induction in synovial fibroblasts by ceramide: in vitro and in vivo effects. 16942485 - Differential effects of insulin-like growth factor-1 and atheroma-associated cytokines ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-8-16 |
Journal Detail:
|
Title: British journal of cancer Volume: - ISSN: 1532-1827 ISO Abbreviation: - Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-8-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370635 Medline TA: Br J Cancer Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Cancer Research UK Clinical Centre, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lung cancer mortality in a cohort of UK cotton workers: an extended follow-up.
Next Document: Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?